» Articles » PMID: 38468689

Amnion-derived Hydrogels As a Versatile Platform for Regenerative Therapy: from Lab to Market

Overview
Date 2024 Mar 12
PMID 38468689
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, the amnion (AM) has emerged as a versatile tool for stimulating tissue regeneration and has been of immense interest for clinical applications. AM is an abundant and cost-effective tissue source that does not face strict ethical issues for biomedical applications. The outstanding biological attributes of AM, including side-dependent angiogenesis, low immunogenicity, anti-inflammatory, anti-fibrotic, and antibacterial properties facilitate its usage for tissue engineering and regenerative medicine. However, the clinical usage of thin AM sheets is accompanied by some limitations, such as handling without folding or tearing and the necessity for sutures to keep the material over the wound, which requires additional considerations. Therefore, processing the decellularized AM (dAM) tissue into a temperature-sensitive hydrogel has expanded its processability and applicability as an injectable hydrogel for minimally invasive therapies and a source of bioink for the fabrication of biomimetic tissue constructs by recapitulating desired biochemical cues or pre-defined architectural design. This article reviews the multi-functionality of dAM hydrogels for various biomedical applications, including skin repair, heart treatment, cartilage regeneration, endometrium regeneration, vascular graft, dental pulp regeneration, and cell culture/carrier platform. Not only recent and cutting-edge research is reviewed but also available commercial products are introduced and their main features and shortcomings are elaborated. Besides the great potential of AM-derived hydrogels for regenerative therapy, intensive interdisciplinary studies are still required to modify their mechanical and biological properties in order to broaden their therapeutic benefits and biomedical applications. Employing additive manufacturing techniques (e.g., bioprinting), nanotechnology approaches (e.g., inclusion of various bioactive nanoparticles), and biochemical alterations (e.g., modification of dAM matrix with photo-sensitive molecules) are of particular interest. This review article aims to discuss the current function of dAM hydrogels for the repair of target tissues and identifies innovative methods for broadening their potential applications for nanomedicine and healthcare.

Citing Articles

Advancements in bioengineered and autologous skin grafting techniques for skin reconstruction: a comprehensive review.

Dean J, Hoch C, Wollenberg B, Navidzadeh J, Maheta B, Mandava A Front Bioeng Biotechnol. 2025; 12():1461328.

PMID: 39840132 PMC: 11747595. DOI: 10.3389/fbioe.2024.1461328.


Amniotic membrane, a novel bioscaffold in cardiac diseases: from mechanism to applications.

Rayat Pisheh H, Darvishi A, Masoomkhah S Front Bioeng Biotechnol. 2025; 12:1521462.

PMID: 39758951 PMC: 11696288. DOI: 10.3389/fbioe.2024.1521462.


The impact of mechanical tuning on the printability of decellularized amniotic membrane bioinks for cell-laden bioprinting of soft tissue constructs.

Kafili G, Tamjid E, Simchi A Sci Rep. 2024; 14(1):29697.

PMID: 39613811 PMC: 11606975. DOI: 10.1038/s41598-024-80973-3.


Application of Fetal Membranes and Natural Materials for Wound and Tissue Repair.

Rouzaire M, Blanchon L, Sapin V, Gallot D Int J Mol Sci. 2024; 25(22).

PMID: 39595963 PMC: 11594142. DOI: 10.3390/ijms252211893.

References
1.
Yuan Z, Nie H, Wang S, Lee C, Li A, Fu S . Biomaterial selection for tooth regeneration. Tissue Eng Part B Rev. 2011; 17(5):373-88. PMC: 3179624. DOI: 10.1089/ten.TEB.2011.0041. View

2.
Abbasi-Kangevari M, Ghamari S, Safaeinejad F, Bahrami S, Niknejad H . Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and.... Front Immunol. 2019; 10:238. PMC: 6391358. DOI: 10.3389/fimmu.2019.00238. View

3.
Luo Y, Shen M, Feng P, Qiu H, Wu X, Yang L . Various administration forms of decellularized amniotic membrane extract towards improving corneal repair. J Mater Chem B. 2021; 9(45):9347-9357. DOI: 10.1039/d1tb01848e. View

4.
Manuelpillai U, Tchongue J, Lourensz D, Vaghjiani V, Samuel C, Liu A . Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl₄-treated mice. Cell Transplant. 2010; 19(9):1157-68. DOI: 10.3727/096368910X504496. View

5.
Cross M, Claesson-Welsh L . FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci. 2001; 22(4):201-7. DOI: 10.1016/s0165-6147(00)01676-x. View